Rationaler for behandling med januskinase ½-hæmning af svært syge patienter med COVID-19-pneumoni

Keyphrases

• Janus Kinase 1 (JAK1) 100%
• Patients with COVID-19 100%
• COVID-19 Pneumonia 100%
• Hemophagocytic Lymphohistiocytosis 66%
• Hyperinflammation 66%
• High Mortality 33%
• Lung 33%
• Virus 33%
• Mechanical Ventilation 33%
• Inhibitor Treatment 33%
• Hematological Diseases 33%
• Acute Respiratory Failure 33%
• COVID-19 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Syndrome 100%
• Janus Kinase 1 100%
• Hemophagocytic Syndrome 66%
• Glucocorticoid 33%
• Hematologic Disease 33%
• Acute Respiratory Failure 33%